Importantly, compared with the ADSC-Ctrl mice, the mice that received intramyocardial ADSC-PP2Cm injection showed better ventricular contractile function after MI, as evidenced by consecutive echocardiography, whereas ADSC-BCKDK failed to improve cardiac function following MI (Fig. 7b). Here, BCKDK is linked to myocardial infarction.